5,859 Shares in Cardinal Health, Inc. $CAH Purchased by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 5,859 shares of the company’s stock, valued at approximately $920,000.

A number of other institutional investors also recently modified their holdings of the stock. SJS Investment Consulting Inc. increased its holdings in shares of Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. American Capital Advisory LLC boosted its position in Cardinal Health by 5,200.0% in the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the last quarter. Vermillion & White Wealth Management Group LLC boosted its position in Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 71 shares during the last quarter. Finally, Quent Capital LLC acquired a new stake in shares of Cardinal Health in the 3rd quarter valued at $35,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $219.24 on Friday. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $233.60. The stock has a market cap of $51.59 billion, a P/E ratio of 31.55, a P/E/G ratio of 1.39 and a beta of 0.65. The firm has a 50 day moving average price of $216.60 and a 200 day moving average price of $191.39.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. During the same period last year, the business posted $1.93 earnings per share. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. Analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, April 1st. Cardinal Health’s payout ratio is presently 29.35%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft boosted their target price on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research report on Tuesday, November 18th. UBS Group set a $260.00 price objective on Cardinal Health and gave the stock a “buy” rating in a report on Friday, February 6th. Wells Fargo & Company upped their target price on shares of Cardinal Health from $237.00 to $256.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Morgan Stanley set a $255.00 target price on shares of Cardinal Health in a research note on Friday, February 6th. Finally, TD Cowen lifted their price target on shares of Cardinal Health from $233.00 to $251.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $245.67.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.